US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Parabilis Medicines

28.02

-0.0750-0.27%

Volume:619.46K

Turnover:17.76M

Market Cap:3.47B

PE:-1.19

High:29.50

Open:28.15

Low:27.74

Close:28.09

52wk High:42.49

52wk Low:24.51

Shares:124.00M

Float Shares:33.50M

Volume Ratio:0.81

T/O Rate:1.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-23.4458

EPS(LYR):-60.0402

ROE:--

ROA:--

PB:3.32

PE(LYR):-0.47

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Sciety Flags Revived US Biotech IPO Market as 20 Listings Raise USD 6.1 Billion in 2026

Parabilis Medicines falls -12.5%

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)

Parabilis Medicines CMO Fawzi Benzaghou to Exit Sept. 30

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBLS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":28.015,"timestamp":1791571146566,"preClose":28.09,"halted":0,"volume":619455,"delay":0,"changeRate":-0.0026699893200426944,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"Trading","change":-0.075,"latestTime":"10-09 14:39:16 EDT","open":28.15,"high":29.5,"low":27.735,"amount":17759735.824335,"amplitude":0.062834,"askPrice":28.12,"askSize":200,"bidPrice":28.01,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":28.09,"preHourTrading":{"tag":"盘前","latestPrice":27.1,"preClose":28.09,"latestTime":"09:06 EDT","volume":10,"amount":270.4409,"timestamp":1791551167202,"change":-0.99,"changeRate":-0.035244,"amplitude":0.0356},"postHourTrading":{"tag":"盘后","latestPrice":28.09,"preClose":28.09,"latestTime":"19:30 EDT","volume":6477,"amount":182203.19,"timestamp":1791502203865,"change":0,"changeRate":0,"amplitude":0.014596},"volumeRatio":0.808482,"impliedVol":0.5894,"impliedVolPercentile":0.4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":0.808482,"shares":124000000,"dividePrice":0,"high":29.5,"amplitude":0.062834,"preClose":28.09,"low":27.735,"week52Low":24.51,"pbRate":"3.32","psRate":"23472.03","week52High":42.485,"institutionHeld":0,"latestPrice":28.015,"committee":-0.99005,"eps":-23.44581,"divideRate":0,"volume":619455,"delay":0,"ttmEps":-23.44581,"open":28.15,"prevYearClose":20,"prevWeekClose":30.28,"prevMonthClose":32.29,"prevQuarterClose":32.29,"fiveDayClose":30.28,"twentyDayClose":36.88,"sixtyDayClose":29.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-10-08","current":-1.194883,"percent":0.97561,"low":-31.159897,"twenty":-28.560162,"median":-25.945757,"eighty":-22.923889,"high":-15.535256,"avg":-25.792262,"sd":2.989022,"marketCap":3560227976},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639},{"date":"2026-08-28","current":-28.461644,"twenty":-28.506557,"median":-25.662561,"eighty":-22.933884,"marketCap":4853620999},{"date":"2026-09-04","current":-29.519266,"twenty":-28.607972,"median":-26.20813,"eighty":-23.085477,"marketCap":5033979530},{"date":"2026-09-11","current":-26.310178,"twenty":-28.726773,"median":-26.487161,"eighty":-23.303097,"marketCap":4486727276},{"date":"2026-09-18","current":-29.613438,"twenty":-28.726773,"median":-26.50382,"eighty":-23.762521,"marketCap":5050038851},{"date":"2026-09-25","current":-23.521241,"twenty":-28.726773,"median":-26.562125,"eighty":-23.80152,"marketCap":4011124302},{"date":"2026-10-02","current":-22.050711,"twenty":-28.623909,"median":-26.310178,"eighty":-23.28336,"marketCap":3760351825},{"date":"2026-10-08","current":-20.877184,"twenty":-28.560162,"median":-25.945757,"eighty":-22.923889,"marketCap":3560227976}],"updateTime":1791571156951},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBLS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670238721","title":"Sciety Flags Revived US Biotech IPO Market as 20 Listings Raise USD 6.1 Billion in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670238721","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670238721?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:14","pubTimestamp":1790586884,"startTime":"0","endTime":"0","summary":"Sciety flags revived US biotech IPO market as 20 listings raise USD 6.1 billion in 2026Sciety flagged a rebound in US biotech investor appetite, marked by stronger IPO issuance and broad sector gains.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8fMDXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669626671","title":"Parabilis Medicines falls -12.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669626671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669626671?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:06","pubTimestamp":1790006778,"startTime":"0","endTime":"0","summary":"Parabilis Medicines (PBLS) is down -12.5%, or -$5.22 to $36.51. Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-falls-12-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-falls-12-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668848968","title":"Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668848968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668848968?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:00","pubTimestamp":1789635634,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-evolus-eols-parabilis-medicines-inc-pbls-and-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-evolus-eols-parabilis-medicines-inc-pbls-and-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS","LABU","HCSG","EOLS","BK4007","XLV","BK4585","BK4137","LU0029874061.USD","LU0128526141.USD","XBI","BK4588","BK4139","BK4539","ABOS","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849667","title":"Parabilis Medicines CMO Fawzi Benzaghou to Exit Sept. 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849667","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849667?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:10","pubTimestamp":1788379827,"startTime":"0","endTime":"0","summary":"Parabilis Medicines CMO Fawzi Benzaghou to exit Sept. 30Parabilis Medicines’ Chief Medical Officer Fawzi Benzaghou will leave the company effective Sept. 30, 2026.The transition was mutually agreed on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9js8fR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBLS\",params:#limit:6,delay:false,,,undefined,":[]}}